Baxter International Inc (BAX)

Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell

$31.20

Buy

$31.21

arrow-down$-0.67 (-2.10%)

Prices updated at 13 May 2025, 18:15 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.
S&P 500
arrow-up0.85%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Mr. D. Brent Shafer
CEO
Mr. D. Brent Shafer
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
38,000
Head office
One Baxter Parkway
Deerfield
United States
60015
mobile
+1 224 948-2000
letter
Global_CORP_Investor_Relations@baxter.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Joel T. Grade
Executive Vice President and Chief Financial Officer
0.81m
Mr. D. Brent Shafer
Interim Chief Executive Officer and Chairman of the Board
0.17m
Ms. Anita A. Zielinski
Senior Vice President, Chief Accounting Officer and Controller
-
Ms. Heather L. Knight
Executive Vice President, Chief Operating Officer and Interim Group President, Medical Products and Therapies
0.88m
Ms. Jeanne K. Mason
Executive Vice President and Chief Human Resources Officer
-
Ms. Patricia B. Morrison
Independent Director
0.13m
Dr. Stephen Newman Oesterle, M.D.
Independent Director
0.14m
Mr. Jeffrey A. Craig
Independent Director
0.04m
Ms. Amy A. Wendell
Independent Director
0.12m
Ms. Nancy M. Schlichting
Lead Independent Director
0.14m
Mr. Stephen H. Rusckowski
Independent Director
0.12m
Mr. James W. Borzi
Executive Vice President and Chief Supply Chain Officer
-
Ms. Catherine R. Smith
Independent Director
0.15m
Mr. Alok Sonig
Executive Vice President and Group President, Pharmaceuticals
0.79m
Dr. David S. Wilkes, M.D.
Independent Director
0.12m
Mr. David S. Rosenbloom
Executive Vice President and General Counsel
-
Mr. Reazur Rasul
Executive Vice President and Group President, Healthcare Systems and Technologies
-
Mr. William A. Ampofo, II
Independent Director
0.11m

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
BlackRock Inc63,551,192
Vanguard Group Inc60,757,002
Dodge & Cox50,377,294
Dodge & Cox Stock Fund35,272,400
Pzena Investment Management, LLC33,638,296

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
31 Dec 2024-
13 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
09 Sep 2024-
03 Sep 2024-
03 Sep 2024-
03 Jun 2024-
03 Jun 2024-
07 May 2024-
07 May 2024-
07 May 2024-
07 May 2024-
07 May 2024-
07 May 2024-
07 May 2024-
07 May 2024-
07 May 2024-
06 Mar 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.